You're eating the way you've always eaten, staying just as active — and the scale keeps creeping up anyway. Dr. Jana Baatenburg explains why that's not a personal failure, what's actually changing in a woman's body composition at midlife, and why the goal should shift from smaller to stronger.

Her mother had breast cancer at forty-eight. Her aunt had ovarian cancer. She's been told to keep an eye on it — but no one has ever walked her through what her own risk actually is. Dr. Kelli Peiffer explains what precision medicine means for women, and how genetic testing turns vague risk into an actual plan.

Ask most women what keeps their bones strong, and the answer comes back fast: calcium. But a woman can hit her calcium target every day and still lose bone if her vitamin D is low, her protein intake is thin, or her estrogen has dropped. Dr. Lindsey Cassidy breaks down what bone strength actually depends on — and why the menopause years change the math.

Many women reach their 40s or 50s convinced their metabolism has simply slowed down. A landmark study tracking over 6,400 people found metabolism actually stays remarkably stable from 20 to 60. Dr. Jana Baatenburg breaks down what's really changing in midlife — and why the scale is the least useful number to watch.

She started waking at 2 a.m. for no clear reason — lying there for an hour while her body temperature swung and her thoughts circled. Dr. Sameena Rahman breaks down why midlife sleep disruption isn't a stress problem, and why "it's probably stress" isn't a real answer.

She's sleeping seven hours, exercising four days a week, eating well — and her labs came back "normal." So why does her energy feel like the voltage dropped? Dr. Sameena Rahman explains why standard fatigue workups miss the real story: an interplay between estrogen, cortisol, and thyroid function that a single TSH test can't capture.

For years, women with PCOS navigated a diagnosis that didn't quite add up. The name pointed to the ovaries. The symptoms pointed everywhere else. On May 12, 2026, a global consortium published a landmark paper in The Lancet formally renaming the condition polyendocrine metabolic ovarian syndrome — PMOS. If your care has never quite addressed what you were actually experiencing, the science now agrees with you.

Most women absorbed the "moderate drinking is fine" message somewhere along the way. The research has moved considerably since then — and it hasn't moved in a reassuring direction. Women metabolize alcohol differently, the liver risk accumulates at lower thresholds than most patients have been told, and the breast cancer signal is consistent and starts at low consumption levels. Here's what the science actually shows.

A significant share of LGBTQ+ adults have delayed or avoided necessary medical care because of past experiences with discrimination in healthcare settings. For transgender and nonbinary individuals, that number is higher still. These are not fringe cases. They are patients who needed care and made the calculation that seeking it was too risky.

On May 12, 2026, a paper published in The Lancet formally renamed polycystic ovary syndrome. The condition affecting one in eight women worldwide is now polyendocrine metabolic ovarian syndrome — PMOS. The name change followed 14 years of global collaboration and consensus across 56 organizations. What it reflects clinically, and what it demands from primary care, is worth understanding.

While men are twice as likely to have a heart attack, heart disease is still the leading cause of death among women. Women are also more likely to experience the subtler symptoms — the ones that don't look like a heart attack until it's too late to act quickly.

One in five women will have a stroke in her lifetime. Women are also more likely to experience the less obvious symptoms — the ones that don't show up on the FAST checklist — which means strokes go unrecognized and untreated more often than they should.

Most people couldn't imagine getting an STI — but the numbers tell a different story. At least 70% of women with chlamydia have no symptoms, and one in 20 sexually active young women aged 14–24 is affected. Here's what you need to know about testing and why it matters.

Menopause, breast health, sexual health, bone health, cardiovascular risk — five topics every woman approaching midlife should be discussing with her doctor. We know starting the conversation isn't always easy. Here's what to say.

Most women have sat in a doctor's office and decided, at the last moment, not to bring something up. That hesitation is understandable. But it comes at a cost — and it does not have to keep happening.

Most women leave their annual visit with the quiet feeling that something important went unasked. That's not a personal failure — it's a structural one. Here's what a well-women's visit should actually cover, and how to walk in ready to get what you need.

Fatigue in your thirties. Brain fog in your forties. Hot flashes in your fifties. You've probably been told it's all normal — but normal isn't an answer. Here's what your hormones are actually doing at every stage of life, and what that means for your care.

Nearly half of all adults will experience a mental health disorder at some point in their lifetime — and women face it differently than men. Women are twice as likely to experience depression, anxiety, and PTSD. That disparity isn't biological. It's social, structural, and worth talking about.

Up to 1 in 3 people in the United States will develop cancer in their lifetime. But not all cancers work the same way — and understanding whether your family history points to a hereditary pattern could be one of the most useful things you do for your long-term health.

After years of questioning priorities — what your time is worth, whether you're doing what you love — more people are making themselves the top priority. The surest path to personal and professional success starts with treating yourself as an investment. Here are five places to begin.